Navigation Links
RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC
Date:1/28/2009

at employees are accessing the most current versions. DCM is integrated with RadPharm's learning management system to achieve compliance related to employee training. Employees are required to read SOPs within 90 days of their employment start date and within 20 days of when an SOP has been approved.

"DCM has streamlined our employee training process," said Guindi. "Before, employees had to track down binders that contain paper-based SOPs. We also used paper to keep track of which employee read which SOP. With an average of 40 SOPs per employee, it meant manually reviewing 20 forms to ensure compliance for a single employee. Multiply hundreds of employees and between 90 to 100 SOPs, the process was very time-consuming."

The transition to electronic-based SOPs also allows RadPharm to better collaborate without losing document control. Radiologists, physicians, oncologists and other employees who are part of clinical project teams have the ability to share and route information and keep track of its state -- who has reviewed and approved the document. This provides RadPharm with an audit trail system to meet regulatory filing requirements.

About EMC Documentum Compliance Manager

EMC Documentum Compliance Manager (DCM) provides an audited environment where users can create, collaborate, review, revise, approve and distribute controlled or regulated content. As a result, it can be used to help customers achieve compliance with external regulations such as 21 CFR Part 11 and internal policies while maintaining high product and service quality standards. DCM 6.5 now provides e-signatures, watermarking and overlays as native Web services to simplify installation and deployment. It also offers XML document support to manage controlled content authored in XML.

About EMC

EMC Corporation (NYSE: '/>"/>

SOURCE EMC Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital
2. Frost & Sullivan Finds Compliance Requirements Drive the Healthcare Security Boom
3. St. Jude finds more than 100 gene variations linked with response to leukemia treatment
4. Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan
5. Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
6. Study Finds High-Fructose Corn Syrup Contains Mercury
7. Cell phones dangerous for child pedestrians, UAB study finds
8. Children with inflammatory bowel disease have surprisingly high folate levels, study finds
9. Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds
10. U.S. Government Finds 40% of People Currently Receiving Long Term Care are 18-64; Numbers Continue to Rise
11. UCSF Finds Potential New Antibody Treatment for Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... March 01, 2015 Women’s Excellence ... Overactive Bladder (OAB) symptoms, such as a strong need to ... type of medication (anticholinergic) does not work well enough or ... that takes another approach to targeting the source of OAB, ... the nerves and bladder muscle, blocking the signals that trigger ...
(Date:3/1/2015)... March 01, 2015 Ticket Down is a ... Chicago at Soldier Field. Deadheads have been anxiously ... January. , Grateful Dead was formed 50 years ago back ... together as one until the untimely death of Jerry Garcia ... different genres including blues, reggae, rock, bluegrass, folk, space rock ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... In a recent episode of SCI ... Change Athlete Development Services and Consultancy talks with ... athlete development and player engagement during and after their ... athletes face and how off-field activities are a critical ... involved in athlete development issues while in graduate school ...
(Date:2/28/2015)... Morristown, NJ (PRWEB) February 28, 2015 ... Month—is a good time to remind ourselves and ... be ignored, say Atlantic NeuroSurgical Specialists (ANS). , ... (TBI), which account for 75% of TBIs. There ... word concussion may sound benign, but it is ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... moderate consumption of alcohol may cut the rate of ... 225 men after they had undergone a percutaneous transluminal ... with a stent. Less traumatic than bypass surgery, a ... in renarrowing of the artery, usually within four months. ...
... in Britain has increased by more than 50 percent over ... as exposure to radiation, benzene, and environmental pollutants, are thought ... ,Research conducted shows that the low incidence of leukemia in ... the spice turmeric, which is widely used in Asian cooking. ...
... cancer is the leading cause of cancer death among men ... // have double the risk of developing lung cancer from ... nearly 3,000 men and women ages 40 and older with ... as age, gender and number of years smoking -- impacted ...
... associated with an increased risk of heart disease and breast ... whether or not to use the treatment. ,Doctors ... around 50 years old who are first facing menopause. These ... hot flashes and night sweats and for them, the treatment ...
... it’s in a more advanced stage is key to survival ... study.// While a CT scan can detect early lung cancer, ... A new study conducted by researchers who wanted to look ... ,The research was part of the Early Lung ...
... focused on depression in elderly people living in the community ... // depression and its symptoms have been shown to accelerate ... 250 participants in a community health program. At the start ... then did so again at 18 months. At the beginning, ...
Cached Medicine News:
(Date:2/27/2015)... CHAPEL HILL, N.C. , Feb. 27, 2015 /PRNewswire/ ... the challenge of managing multiple products for the same ... especially for those that want to prevent one of ... of another.  According to recent research by ... promoted their products as independent brands rather than together ...
(Date:2/27/2015)... SHANGHAI , Feb. 27, 2015 WuXi ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... breakthrough therapy designation from the U.S. FDA for ibalizumab ... therapy if it is intended, alone or in combination ...
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... in the Proceedings of the National Academy ... when ibrutinib (IMBRUVICA ® ) was combined with ... tumor growth was enhanced suggesting a greater response ... and solid tumors with the combination. IMBRUVICA is ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9
... Henry Schein, Inc. (NASDAQ: HSIC ), the ... practitioners, announced today that Ferdinand Jahnel, Vice President ... 9th Annual Best Ideas Conference 2011. The conference is taking ... Henry Schein,s presentation is scheduled to begin ...
... WOODLANDS, Texas, Sept. 13, 2011 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... and mechanistic study of LX4211, a dual inhibitor of ... SGLT2).  The favorable safety profile and effects on multiple ...
Cached Medicine Technology:Henry Schein to Present at the CL King 9th Annual Best Ideas Conference 2011 2LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects 2LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects 3LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects 4
Microforceps : Eckardt End & Side Gripping Forceps...
Blunt tipped forceps wlth a small grasping platform on each tip. For grasping fine membranes or grasping membranes adherent to the retinal surface....
Microforceps: Spaid Pic Forceps...
Blunt tipped forceps with small, slightly pointed grasping platforms on each tip. For general purpose (fine) membrane grasping and grasping membranes adherent to the retlnal surface....
Medicine Products: